Lei He
Research Subjects
Lei He has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Aleix Prat
Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain
7 shared publications Celina García-García
7 shared publicationsClaudia Aura
7 shared publications- Isabel Teresa Rubio
Breast Surgical Oncology Unit, Clinica Universidad de Navarra, Madrid, Spain
7 shared publications - Javier Cortés
Medica Scientia Innovation Research (MedSIR), Barcelona, Spain
7 shared publications - Jordi Rodon
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
7 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
PDF file - 162K, Western blot of cell lysates from MDA-MB-468 or PDC44 cells treated with 750nM and 500nM BKM120 respectively for 4 days using the indicated antibodies
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
PDF file - 162K, Western blot of cell lysates from MDA-MB-468 or PDC44 cells treated with 750nM and 500nM BKM120 respectively for 4 days using the indicated antibodies
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
PDF file - 3.4MB, Concordance in ER, PR, HER2, and PTEN expression between original patient tumors and the derived tumor grafts
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
PDF file - 3.4MB, Concordance in ER, PR, HER2, and PTEN expression between original patient tumors and the derived tumor grafts
- Open Access
- 22 May 2012
- Published by International Speech Communication Association
- p. 466-469
Syllabic intensity variations as quantification of speech rhythm: evidence from both L1 and L2
In this study, three intensity metrics (ΔS.dB, VarcoS.dB and nPVI.dB) devised on the basis of the well-known durational metrics were tested on both L1 (English and Mandarin) and L2 (L2 English). The results suggested that they were effective in distinguishing "stress-timed" English from perceptually "syllable-timed" Mandarin and L2 English (by Mandarin speakers). These metrics break the impasse that although the L1 and L2 varieties of English were similar on durational measurements, they were perceptually different in rhythmicity [22, 23]. Therefore, it is advised that intensity metrics be applied in future rhythm research.
- 22 May 2012
- Published by International Speech Communication Association
- p. 466-469
Open AccessSyllabic intensity variations as quantification of speech rhythm: evidence from both L1 and L2
In this study, three intensity metrics (ΔS.dB, VarcoS.dB and nPVI.dB) devised on the basis of the well-known durational metrics were tested on both L1 (English and Mandarin) and L2 (L2 English). The results suggested that they were effective in distinguishing "stress-timed" English from perceptually "syllable-timed" Mandarin and L2 English (by Mandarin speakers). These metrics break the impasse that although the L1 and L2 varieties of English were similar on durational measurements, they were perceptually different in rhythmicity [22, 23]. Therefore, it is advised that intensity metrics be applied in future rhythm research.